Outside a Tuesday morning H1N1 clinic in Avon parents and seniors waiting in line had not yet heard about the recall of more than 170,000 doses of H1N1 flu vaccine distributed in Canada.
The recall announced Monday by pharmaceutical giant GlaxoSmithKline is a result of higher than expected occurrences of side effects that can include respiratory failure. The side effect is known as anaphylaxis.
Even if the doses are in Canada it's the last news parents wanted to hear.
"A little leary. I've heard lots of good and bad so it makes you kind of wonder especially when you're giving it to your kids," Alexis Hall of Indianapolis said.
According to a statement released Tuesday by the State Health Department, " Indiana has not received any GlaxoSmithKline manufactured H1N1 vaccine to date."
Jordan Gorgievski with Preferred Home Health Care says safety concerns are not a hot topic before, during, or after the injection or mist is administered.
"We've given about 5,000 doses between this clinic and the schools. Today we have about 700 vaccinations to give," Gorgievski said.
The vaccination may make some children cry today, but parents and grandparents can only hope it keeps them safe later.
Hall says she's one of those parents.
"I am weighing my options and praying that everything works out."